Circulating mutant DNA to assess tumor dynamics
Frank Diehl, Kerstin Schmidt, Michael A. Choti et al. · Nature Medicine · 2008
Cited by 2,734 works. doi:10.1038/nm.1789
Authors
- Frank Diehl
- Michael A. Choti
- Katharine E. Romans
- Steven N. Goodman
- Katherine Anne Thornton
- Nishant Agrawal
- Lori J. Sokoll
- Steve Szabo
- Kenneth W. Kinzler
- Bert Vogelstein
- Luis Alberto Diaz
References
- Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
- The Genomic Landscapes of Human Breast and Colorectal Cancers
- Advanced sequencing technologies: methods and goals
- Isolation of rare circulating tumour cells in cancer patients by microchip technology
- Transforming single DNA molecules into fluorescent magnetic particles for detection and enumeration of genetic variations
- Detection and quantification of mutations in the plasma of patients with colorectal tumors
- Emerging molecular markers of cancer
- BEAMing: single-molecule PCR on microparticles in water-in-oil emulsions
- BEAMing up for detection and quantification of rare sequence variants
- Circulating free DNA in plasma or serum as biomarker of carcinogenesis: Practical aspects and biological significance